Return to homepagePandemic Pact

to provide timely, optimized dosing recommendations of re-purposed and new medications to combat COVID-19

Grant number: INV-017319

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020

  • Known Financial Commitments (USD)

    $931

  • Funder

    Gates Foundation

  • Research Location

    United Kingdom

  • Lead Research Institution

    University of Oxford

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

N/A

1 Publication linked via Europe PMC

Last Updated:4 days ago

View all publications at Europe PMC

A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.